Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Assembly Biosciences (ASMB) EPS (Weighted Average and Diluted): 2019-2025

Historic EPS (Weighted Average and Diluted) for Assembly Biosciences (ASMB) over the last 4 years, with Sep 2025 value amounting to -$0.72.

  • Assembly Biosciences' EPS (Weighted Average and Diluted) rose 52.32% to -$0.72 in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.79, marking a year-over-year increase of 30.78%. This contributed to the annual value of -$6.69 for FY2024, which is 50.00% up from last year.
  • Latest data reveals that Assembly Biosciences reported EPS (Weighted Average and Diluted) of -$0.72 as of Q3 2025, which was up 45.86% from -$1.33 recorded in Q2 2025.
  • In the past 5 years, Assembly Biosciences' EPS (Weighted Average and Diluted) ranged from a high of -$0.41 in Q3 2021 and a low of -$4.46 during Q1 2023.
  • In the last 3 years, Assembly Biosciences' EPS (Weighted Average and Diluted) had a median value of -$1.66 in 2024 and averaged -$2.12.
  • Data for Assembly Biosciences' EPS (Weighted Average and Diluted) shows a peak YoY spiked of 62.78% (in 2024) over the last 5 years.
  • Quarterly analysis of 4 years shows Assembly Biosciences' EPS (Weighted Average and Diluted) stood at -$1.37 in 2021, then reached -$1.77 in 2023, then climbed by 11.30% to -$1.57 in 2024, then soared by 52.32% to -$0.72 in 2025.
  • Its last three reported values are -$0.72 in Q3 2025, -$1.33 for Q2 2025, and -$1.17 during Q1 2025.